The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.
Open accessAbstract
Phorbol esters bind to and activate a calcium phospholipid-dependent protein kinase (C kinase). Some researchers believe that activation of C kinase is necessary for the induction of phorbol ester biologic effects. Our research indicates that bryostatin, a macrocyclic lactone that binds to the phorbol ester receptor in human polymorphonuclear leukocytes, also binds to this receptor in the human promyelocytic leukemia cell line, HL-60. Bryostatin activates partially purified C kinase from HL-60 cells in vitro, and when applied to HL-60 cells in vivo, it decreases measurable cytoplasmic C kinase activity. Unlike the phorbol esters, bryostatin is unable to induce a macrophage-like differentiation of HL-60 cells; however, bryostatin, in a dose-dependent fashion, blocks phorbol ester-induced differentiation of HL-60 cells and, if applied within 48 hr of phorbol esters, halts further differentiation. These results suggest that activation of the C kinase by some agents is not sufficient for induction of HL-60 cell differentiation and imply that some of the biologic effects of phorbol esters may occur through a more complex mechanism than previously thought.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of protein kinase C in cell surface signal transduction and tumour promotion
Nishizuka, Y. (1984) · Nature · doi:10.1038/308693a0 · Cited by 7,454
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725
Kraft, A. S., & Anderson, W. B. (1983) · Nature · doi:10.1038/301621a0 · Cited by 1,291
Self-citationPhorbol diester receptor copurifies with protein kinase C.
Niedel, J. E., Kuhn, L. J., & Vandenbark, G. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.36 · Cited by 1,169
Rovera, G., Santoli, D., & Damsky, C. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.6.2779 · Cited by 985
Cochet, C., Gill, G. N., Meisenhelder, J., Cooper, J. A., & Hunter, T. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43389-8 · Cited by 711
Huberman, E., & Callaham, M. F. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1293 · Cited by 500
Kraft, A. S., Anderson, W. B., Cooper, H. L., & Sando, J. J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33427-6 · Cited by 412
Self-citationSugden, D., Vanecek, J., Klein, D. C., Thomas, T. P., & Anderson, W. B. (1985) · Nature · doi:10.1038/314359a0 · Cited by 412
Rozengurt, E., Rodriguez-Pena, M., & Smith, K. A. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.23.7244 · Cited by 372
Cited by
Collins, S. (1987) · Blood · doi:10.1182/blood.v70.5.1233.1233 · Cited by 1,190
Protein kinase C, an elusive therapeutic target?
Mochly-Rosen, D., Das, K., & Grimes, K. V. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3871 · Cited by 563
Review of survival analyses published in cancer journals
Altman, D., De Stavola, B., Love, S., & Stepniewska, K. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.364 · Cited by 438
Protein kinase C: perfectly balanced
Newton, A. C. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1442408 · Cited by 335
RasGRP links T-cell receptor signaling to Ras
Ebinu, J. O., Stang, S. L., Teixeira, C., Bottorff, D. A., Hooton, J., Blumberg, P. M., Barry, M., Bleakley, R. C., Ostergaard, H. L., & Stone, J. C. (2000) · Blood · doi:10.1182/blood.v95.10.3199 · Cited by 327
Davidson, S. K., Allen, S. W., Lim, G. E., Anderson, C. M., & Haygood, M. G. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.10.4531-4537.2001 · Cited by 275
Protein kinase C and the activation of the human neutrophil NADPH- oxidase
Tauber, A. (1987) · Blood · doi:10.1182/blood.v69.3.711.711 · Cited by 274
Ara-C: Cellular and Molecular Pharmacology
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60703-4 · Cited by 272
Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression
Isakov, N. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.012 · Cited by 270
The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation
Clemens, M. J., Trayner, I., & Menaya, J. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.4.881 · Cited by 266
Bryostatin-1: A novel PKC inhibitor in clinical development
Kortmansky, J., & Schwartz, G. K. (2003) · Cancer Investigation · doi:10.1081/cnv-120025095 · Cited by 183
“Bryostatin-1 is a macrocyclic lactone derived from a marine invertebrate that binds to the regulatory domain of protein kinase C. Short-term exposure to bryostatin-1 promotes activation of PKC, whereas prolonged exposure promotes significant downregulation of PKC.”
BackgroundInfluentialEquivocal, explicit and emergent actions of PKC isoforms in cancer
Parker, P. J., Brown, S. J., Calleja, V., Chakravarty, P., Cobbaut, M., Linch, M., Marshall, J. J. T., Martini, S., McDonald, N. Q., Soliman, T., et al. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00310-4 · Cited by 65
Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition
Carey, J., Posekany, K., deVente, J., Pettit, G., & Ways, D. (1996) · Blood · doi:10.1182/blood.v87.10.4316.bloodjournal87104316 · Cited by 58
Dissociation of c-fos Induction from Macrophage Differentiation in Human Myeloid Leukemic Cell Lines
Calabretta, B. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.769-774.1987 · Cited by 34
(2000) · PubMed · Cited by 21
Malik, A. U., Karapetsas, A., Nirujogi, R. S., Chatterjee, D., Phung, T. K., Wightman, M., Gourlay, R., Morrice, N., Mathea, S., Knapp, S., et al. (2022) · Biochemical Journal · doi:10.1042/bcj20220308 · Cited by 13
Metadata
- Authors
- Kraft, A. S., Smith, J. B., & Berkow, R. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-03
- Volume
- 83
- Issue
- 5
- Pages
- 1334-1338
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1981880855
- Cited by
- 252
- References
- 33
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.